ON BALANCE VOLUME
Trading: SELL @ $1.12
Signal Strength: MEDIUM
Nanthealth (NASDAQ:NH) current price has highlighted recent distribution. Currently, the OBV is -10159.7.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading exit. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
On Balance Volume (OBV) attempts to measure the level of accumulation or distribution by comparing volume to price movements. Volume is added to the indicator if closing price moves up and subtracted if closing price moves down. No adjustment is made if closing price is unchanged.
Calculation: On Balance Volume:
1) If the closing price is above the prior close price then: Current OBV = Previous OBV + Current Volume;
2) If the closing price is below the prior close price then: Current OBV = Previous OBV - Current Volume;
3) If the closing prices equals the prior close price then: Current OBV = Previous OBV (no change)
PROFILE: Nanthealth (NH)
Stock Exchange: NASDAQ
Ticker Codes: | NH | NASDAQ:NH |
NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
On Balance VolumeDownload
|AKAO Achaogen Inc||1.95||8.3||1,429,545||-804,749.2||BEARISH|
|CSII Cardiovascular Syst||30.23||5||383,299||-24,061.9||BEARISH|
|WVE WAVE Life Sciences||40.76||4.8||83,673||-28,896||BEARISH|
|ACHN Achillion Pharmaceuticals||2.9||4.7||1,981,066||-216,566.4||BEARISH|
|AMAT Applied Materials||35.77||3.9||25,063,667||-382,622.5||BEARISH|
|TAST Carrols Rstrnt||11.46||3.9||305,871||-41,687.7||BEARISH|
|CSGP Costar Inc||361.22||3.2||394,662||-30,039||BEARISH|